Technology

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

An app designed by researchers at the University of Virginia is proving that 'warm technology' - personalized and personal - can have an impact on patient engagement and care management.

An app designed by researchers at the University of Virginia is proving that 'warm technology' - personalized and personal - can have an impact on patient engagement and care management.

The UVA Center for Engineering in Medicine promotes innovation by embedding engineering students into clinical environments and nursing and medical trainees into engineering laboratories.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

The UVA Center for Engineering in Medicine promotes innovation by embedding engineering students into clinical environments and nursing and medical trainees into engineering laboratories.

Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

UVA's Center for Applied Biomechanics is taking a leadership role in analyzing populations with heightened vulnerability to traffic-related injury or death, specifically women and obese passengers.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).